First Tracks Biotherapeutics TRAX
NASDAQ TRAX
$46.56 -0.54 (-1.15%)
At close: Nov 16, 2026 · 4:00 PM EST

First Tracks Biotherapeutics (TRAX) Operating Expenses (2025 - 2026)

Updated

Analysis

First Tracks Biotherapeutics (TRAX) Operating Expenses (2025 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Opex (Qtr)
1 Eli Lilly 1,276.89 Bn 1,250.50 Bn 20.46 Bn 15.99 Bn
2 Johnson & Johnson 681.31 Bn 601.18 Bn 17.30 Bn 11.12 Bn
3 AbbVie 520.63 Bn 488.64 Bn 13.12 Bn 11.14 Bn
4 Merck 357.22 Bn 320.16 Bn 13.19 Bn 12.53 Bn
5 Novartis Ag 310.90 Bn 284.14 Bn - -
6 Astrazeneca 285.12 Bn 258.77 Bn 13.26 Bn 9.00 Bn
7 Amgen 250.23 Bn 201.89 Bn 7.58 Bn 6.66 Bn
8 Gilead Sciences 207.56 Bn 182.67 Bn 6.73 Bn 4.84 Bn
9 Pfizer 164.42 Bn 111.77 Bn 12.56 Bn 7.09 Bn
10 First Tracks Biotherapeutics 1.66 Bn 740.14 Mn - 32.84 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 32.84 Mn
Jun 30, 2026 34.94 Mn
Mar 31, 2026 52.81 Mn
Dec 31, 2025 36.77 Mn
Sep 30, 2025 45.06 Mn
Jun 30, 2025 45.90 Mn
Mar 31, 2025 51.28 Mn
API Access

First Tracks Biotherapeutics Operating Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-expenses&ticker=TRAX&period=max&api_key=YOUR_API_KEY